Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609297 · ClinicalTrials.gov registry record
Pain Control in Hospice Patients With Cancer-Related Pain
A clinical trial of Pain and Solid Tumor, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT00609297: Completed study of Pain and Solid Tumor, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00609297 is a study of Pain and Solid Tumor that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 22 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00609297, a study of Pain and Solid Tumor, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Gathering information over time about cancer-related pain from patients in a hospice and their caregivers may help doctors learn more about pain control. PURPOSE: This clinical trial is studying how well standard pain control works in hospice patients with cancer-related pain.
Conditions Studied
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- OTHER survey administration
Study Locations (1)
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-05 |
What the finished NCT00609297 record still lists
NCT00609297 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which medical chart review is the first listed.
NCT00609297 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00609297 about?
NCT00609297 is a clinical study titled "Pain Control in Hospice Patients With Cancer-Related Pain". RATIONALE: Gathering information over time about cancer-related pain from patients in a hospice and their caregivers may help doctors learn more about pain control. PURPOSE: This clinical trial is studying how well standard pain control works in hospice patients with cancer-related pain.
What is the current status of trial NCT00609297?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2007-07. Estimated completion is 2011-05.
What conditions does trial NCT00609297 study?
This clinical trial studies the following conditions: Pain, Solid Tumor.
What interventions are being tested in trial NCT00609297?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), survey administration (OTHER).
Who is sponsoring clinical trial NCT00609297?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00609297 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00609297's enrollment target sits among peer trials
22 335th of 374 higher than 39 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia